Attention-deficit hyperactivity disorder epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 11: | Line 11: | ||
==Gender== | ==Gender== | ||
10% of males, and (only) 4% of females have been diagnosed in the U.S.<ref> {{PDFlink|[http://www.cdc.gov/nchs/data/series/sr_10/sr10_221.pdf "National Health Interview survey, 2002"]|3.71 [[Mebibyte|MiB]]<!-- application/pdf, 3892622 bytes -->}}. Centers for Disease Control (March, 2004). Retrieved on [[December 11]], [[2006]].</ref> This apparent sex difference may reflect either a difference in susceptibility or that females with ADHD are less likely to be diagnosed than males.<ref>Staller J, Faraone SV. (2006) "Attention-deficit hyperactivity disorder in girls: epidemiology and management." ''CNS Drugs''. 2006;20(2):107–23. PMID 16478287</ref><ref>Biederman J, Faraone SV. (2004) "The [[Massachusetts General Hospital]] studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives." ''Psychiatr Clin North Am''. Jun;27(2):225–32. PMID 15063995</ref> | 10% of males, and (only) 4% of females have been diagnosed in the U.S.<ref> {{PDFlink|[http://www.cdc.gov/nchs/data/series/sr_10/sr10_221.pdf "National Health Interview survey, 2002"]|3.71 [[Mebibyte|MiB]]<!-- application/pdf, 3892622 bytes -->}}. Centers for Disease Control (March, 2004). Retrieved on [[December 11]], [[2006]].</ref> This apparent sex difference may reflect either a difference in susceptibility or that females with ADHD are less likely to be diagnosed than males.<ref>Staller J, Faraone SV. (2006) "Attention-deficit hyperactivity disorder in girls: epidemiology and management." ''CNS Drugs''. 2006;20(2):107–23. PMID 16478287</ref><ref>Biederman J, Faraone SV. (2004) "The [[Massachusetts General Hospital]] studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives." ''Psychiatr Clin North Am''. Jun;27(2):225–32. PMID 15063995</ref> | ||
==References== | |||
{{Reflist|2}} | |||
Revision as of 23:46, 11 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
|
Attention-deficit hyperactivity disorder Microchapters |
|
Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Template:Attention-deficit hyperactivity disorder On the Web |
|
American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder epidemiology and demographics |
|
FDA on Attention-deficit hyperactivity disorder epidemiology and demographics |
|
CDC on Attention-deficit hyperactivity disorder epidemiology and demographics |
|
Attention-deficit hyperactivity disorder epidemiology and demographics in the news |
|
Blogs on Attention-deficit hyperactivity disorder epidemiology and demographics |
|
Directions to Hospitals Treating Attention-deficit hyperactivity disorder |
Overview
A review of 102 studies estimated ADHD's worldwide prevalence in people under the age of 19 to be 5.29%. 10% of males, and 4% of females have been diagnosed in the U.S.[1]
Prevalance
A review of 102 studies estimated ADHD's worldwide prevalence in people under the age of 19 to be 5.29%. There was wide variability in prevalence estimates, mostly due to the methodological characteristics of studies (for example, diagnostic criteria used) and, to a lesser extent, geographic location (North America having a significantly higher rate of ADHD than Africa and the Middle East).[2]
Gender
10% of males, and (only) 4% of females have been diagnosed in the U.S.[3] This apparent sex difference may reflect either a difference in susceptibility or that females with ADHD are less likely to be diagnosed than males.[4][5]
References
- ↑ Template:PDFlink. Centers for Disease Control (March, 2004). Retrieved on December 11, 2006.
- ↑ Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007). "The worldwide prevalence of ADHD: a systematic review and metaregression analysis". Am J Psychiatry. 164 (6): 942–48. doi:10.1176/appi.ajp.164.6.942. PMID 17541055.
- ↑ Template:PDFlink. Centers for Disease Control (March, 2004). Retrieved on December 11, 2006.
- ↑ Staller J, Faraone SV. (2006) "Attention-deficit hyperactivity disorder in girls: epidemiology and management." CNS Drugs. 2006;20(2):107–23. PMID 16478287
- ↑ Biederman J, Faraone SV. (2004) "The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives." Psychiatr Clin North Am. Jun;27(2):225–32. PMID 15063995